LCN2 and cutaneous mastocytosis: In the current study, we found the CSF NGAL in patients with BM was significantly higher than those with TBM, CM, and HC, and the CSF NGAL would be serve as a novel and superior biomarker to distinguish BM from those with suspected CNS infection, particularly when a differential diagnosis is needed from patients with TBM or CM.